IlluminaILMN
Life science tools · NASDAQ · USA
$264.57
Down 1.2% todayClose
Up 104.1% this year and +49.9% since June 26, ahead of the life science sector at +10.7%. Illumina supplies 5 mapped companies.
Supply chain
5 customersCustomers 5
About Illumina
DNA sequencing machines and the reagents they consume, for research and clinical genomics.
Theme exposure
Products
- Sequencing instruments
- Consumables (reagents)
- Genomics software
Competitors
- Thermo Fisher
- PacBio
- MGI
Risks
- Competition in sequencing
- Cyclical research demand
Same segment: Life science tools
Instruments, reagents and equipment for research, development and production. Segment 5 of 8 in the Medicine, pharma & life science value chain.
Compare ILMN
Side by side with the largest companies in the same segment.
See where Illumina sits in the full Medicine, pharma & life science map: every segment from upstream suppliers to end markets, with daily metrics.
Open the Life science value chain →